Abstract
Purpose
Astroblastomas (AB) are high-grade neoplasms which typically occur within the cerebral hemisphere. However, given the rarity of this neoplasm and the number of variants, the relevance of this molecular makeup is unknown. We sought to describe the clinical presentation, treatment, and pathological analysis of a novel MN1 (meningioma 1) cervical spinal cord astroblastoma variant presenting in a pediatric patient.
Methods
A retrospective review of electronic medical records was performed with an emphasis on neuroimaging, perioperative course, and pathological analysis.
Results
An 11-month-old male with no significant history presented with two weeks of neck stiffness and cervicalgia. Neurologically, the patient was intact without signs of infection or trauma. Cervical CT was unremarkable. A subsequent MRI demonstrated a heterogeneously enhancing intramedullary lesion extending from the craniocervical junction to T4. The patient was treated with perioperative steroids and underwent C1-C3 laminectomies and C4-T4 laminotomies for tumor resection. Upon completion of the durotomy, an exophytic gray-red tumor was appreciated within the epidural space and gross total resection was achieved (no change on intraoperative neurophysiological monitoring) and confirmed on post-operative imaging. Immunohistochemical analysis was consistent with an astroblastoma with atypical diffuse positivity of CD56, CD99, and nuclear OLIG2. Molecular analysis revealed not only MN1 alterations but also changes in genes encoding APC and LRP1B. Both alterations were not previously documented to be associated with an astroblastoma.
Conclusion
Our case represents the first report of an infant with an MN1 astroblastoma with APC and LRP1B gene alterations in the cervical spine. Gross total resection paired with a detailed histopathologic analysis is vital for optimizing adjuvant treatment.
Similar content being viewed by others
Availability of data and material
There is no associated data for this study.
Abbreviations
- AB:
-
Astroblastoma
- MN1:
-
Meningioma 1
- AML:
-
Acute myeloid leukemia
- APC:
-
Adenomatous polyposis coli
- LRP1B:
-
Low-density lipoprotein receptor-related protein 1B
- IHC:
-
Immunohistochemical
References
Harrison HH, Packer RJ, Rorke LB, Schut L, Sutton LN, Bruce DA (1987) Outcome of children with primary intramedullary spinal cord tumors. Childs Nerv Syst 3:89–92. PMID: 3040249
WHO Classification of Tumours Editorial Board (2021) Central nervous system tumours. Lyon (France): International Agency for Research on Cancer [cited 2022, 09, 15 ]. (WHO classification of tumours series, 5th ed.; vol. 6). Available from: https://tumourclassification.iarc.who.int/chapters/45
Shafik RE, Hassan NM, El Meligui YM, Shafik HE (2017) The meningioma 1 (MN1) gene is an independent poor prognostic factor in adult Egyptian acute myeloid leukemia patients. Asian Pac J Cancer Prev 18(3):609–613. https://doi.org/10.22034/APJCP.2017.18.3.609. PMID: 28440611; PMCID: PMC5464473
Chen W, Soon YY, Pratiseyo PD, Sutanto R, Hendriansyah L, Kuick CH, Chang KTE, Tan CL (2020) Central nervous system neuroepithelial tumors with MN1-alteration: an individual patient data meta-analysis of 73 cases. Brain Tumor Pathol 37(4):145–153. https://doi.org/10.1007/s10014-020-00372-0. Epub 2020 Jun 29. PMID: 32601775
Lehman NL, Usubalieva A, Lin T, Allen SJ, Tran QT, Mobley BC, McLendon RE, Schniederjan MJ, Georgescu MM, Couce M, Dulai MS, Raisanen JM, Al Abbadi M, Palmer CA, Hattab EM, Orr BA (2019) Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis. Acta Neuropathol Commun 7(1):42. https://doi.org/10.1186/s40478-019-0689-3. PMID: 30876455; PMCID: PMC6419470
Shin SA, Ahn B, Kim SK, Kang HJ, Nobusawa S, Komori T, Park SH (2018) Brainstem astroblastoma with MN1 translocation. Neuropathology 38(6):631–637. https://doi.org/10.1111/neup.12514. Epub 2018 Sep 20. PMID: 30238518
Tsutsui T, Arakawa Y, Makino Y, Kataoka H, Mineharu Y, Naito K, Minamiguchi S, Hirose T, Nobusawa S, Nakano Y, Ichimura K, Haga H, Miyamoto S (2021) Spinal cord astroblastoma with EWSR1-BEND2 fusion classified as HGNET-MN1 by methylation classification: a case report. Brain Tumor Pathol 38(4):283–289. https://doi.org/10.1007/s10014-021-00412-3. Epub 2021 Jul 27. PMID: 34313881
Yamada SM, Tomita Y, Shibui S, Takahashi M, Kawamoto M, Nobusawa S, Hirato J (2018) Primary spinal cord astroblastoma: case report. J Neurosurg Spine 28(6):642–646. https://doi.org/10.3171/2017.9.SPINE161302. Epub 2018 Mar 2. PMID: 29498581
Rao S, Nufina TA, Sugur H, Arumalla K, Devi BI, Santosh V (2022) Spinal astroblastoma: a rare tumour in an unusual location. Childs Nerv Syst 38(9):1797–1801. https://doi.org/10.1007/s00381-022-05468-w. Epub 2022 Feb 12. PMID: 35152342
Hirano H, Yunoue S, Kaji M, Tsuchiya M, Arita K (2008) Consecutive histological changes in an astroblastoma that disseminated to the spinal cord after repeated intracranial recurrences: a case report. Brain Tumor Pathol 25(1):25–31. https://doi.org/10.1007/s10014-007-0224-2. Epub 2008 Apr 16. PMID: 18415663
Lucas CG, Gupta R, Wu J, Shah K, Ravindranathan A, Barreto J, Gener M, Ginn KF, Prall OWJ, Xu H, Kee D, Ko HS, Yaqoob N, Zia N, Florez A, Cha S, Perry A, Clarke JL, Chang SM, Berger MS, Solomon DA (2022) EWSR1-BEND2 fusion defines an epigenetically distinct subtype of astroblastoma. Acta Neuropathol 143(1):109–113. https://doi.org/10.1007/s00401-021-02388-y. Epub 2021 Nov 25. PMID: 34825267; PMCID: PMC8732961
Yamasaki K, Nakano Y, Nobusawa S, Okuhiro Y, Fukushima H, Inoue T, Murakami C, Hirato J, Kunihiro N, Matsusaka Y, Honda-Kitahara M, Ozawa T, Shiraishi K, Kohno T, Ichimura K, Hara J (2020) Spinal cord astroblastoma with an EWSR1-BEND2 fusion classified as a high-grade neuroepithelial tumour with MN1 alteration. Neuropathol Appl Neurobiol 46(2):190–193. https://doi.org/10.1111/nan.12593. Epub 2020 Jan 8. PMID: 31863478
Wood MD, Tihan T, Perry A, Chacko G, Turner C, Pu C, Payne C, Yu A, Bannykh SI, Solomon DA (2018) Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities. Brain Pathol 28(2):192–202. https://doi.org/10.1111/bpa.12561. Epub 2017 Oct 27. PMID: 28960623; PMCID: PMC5843525
Lekanne Deprez RH, Riegman PH, Groen NA, Warringa UL, van Biezen NA, Molijn AC, Bootsma D, de Jong PJ, Menon AG, Kley NA et al (1995) Cloning and characterization of MN1, a gene from chromosome 22q11, which is disrupted by a balanced translocation in a meningioma. Oncogene 10(8):1521–1528. PMID: 7731706
Meester-Smoor MA, Vermeij M, van Helmond MJ, Molijn AC, van Wely KH, Hekman AC, Vermey-Keers C, Riegman PH, Zwarthoff EC (2005) Targeted disruption of the Mn1 oncogene results in severe defects in development of membranous bones of the cranial skeleton. Mol Cell Biol 25(10):4229–4236. https://doi.org/10.1128/MCB.25.10.4229-4236.2005. PMID: 15870292; PMCID: PMC1087735
Buijs A, Sherr S, van Baal S, van Bezouw S, van der Plas D, Geurts van Kessel A, Riegman P, Lekanne Deprez R, Zwarthoff E, Hagemeijer A et al (1995) Translocation (12;22) (p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. Oncogene 10(8):1511–1519. Erratum in: Oncogene 1995 Aug 17;11(4):809. PMID: 7731705
Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DTW, Capper D, Sill M, Buchhalter I, Northcott PA, Leis I, Ryzhova M, Koelsche C, Pfaff E, Allen SJ, Balasubramanian G, Worst BC, Pajtler KW, Brabetz S, Johann PD, Sahm F, Reimand J, Mackay A, Carvalho DM, Remke M, Phillips JJ, Perry A, Cowdrey C, Drissi R, Fouladi M, Giangaspero F, Łastowska M, Grajkowska W, Scheurlen W, Pietsch T, Hagel C, Gojo J, Lötsch D, Berger W, Slavc I, Haberler C, Jouvet A, Holm S, Hofer S, Prinz M, Keohane C, Fried I, Mawrin C, Scheie D, Mobley BC, Schniederjan MJ, Santi M, Buccoliero AM, Dahiya S, Kramm CM, von Bueren AO, von Hoff K, Rutkowski S, Herold-Mende C, Frühwald MC, Milde T, Hasselblatt M, Wesseling P, Rößler J, Schüller U, Ebinger M, Schittenhelm J, Frank S, Grobholz R, Vajtai I, Hans V, Schneppenheim R, Zitterbart K, Collins VP, Aronica E, Varlet P, Puget S, Dufour C, Grill J, Figarella-Branger D, Wolter M, Schuhmann MU, Shalaby T, Grotzer M, van Meter T, Monoranu CM, Felsberg J, Reifenberger G, Snuderl M, Forrester LA, Koster J, Versteeg R, Volckmann R, van Sluis P, Wolf S, Mikkelsen T, Gajjar A, Aldape K, Moore AS, Taylor MD, Jones C, Jabado N, Karajannis MA, Eils R, Schlesner M, Lichter P, von Deimling A, Pfister SM, Ellison DW, Korshunov A, Kool M (2016) New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 164(5):1060–1072. https://doi.org/10.1016/j.cell.2016.01.015. PMID: 26919435; PMCID: PMC5139621
Petruzzellis G, Alessi I, Colafati GS, Diomedi-Camassei F, Ciolfi A, Pedace L, Cacchione A, Carai A, Tartaglia M, Mastronuzzi A, Miele E (2019) Role of DNA methylation profile in diagnosing astroblastoma: a case report and literature review. Front Genet 30(10):391. https://doi.org/10.3389/fgene.2019.00391. PMID: 31114608; PMCID: PMC6502896
Chadda KR, Holland K, Scoffings D, Dean A, Pickles JC, Behjati S, Jacques TS, Trotman J, Tarpey P, Allinson K, Murray MJ, Genomics England Research Consortium (2021) A rare case of paediatric astroblastoma with concomitant MN1-GTSE1 and EWSR1-PATZ1 gene fusions altering management. Neuropathol Appl Neurobiol 47(6):882–888. https://doi.org/10.1111/nan.12701. Epub 2021 Feb 22. PMID: 33534137
Burel-Vandenbos F, Pierron G, Thomas C, Reynaud S, Gregoire V, de Benaze GD, Croze S, Chivoret N, Honavar M, Figarella-Branger D, Maurage CA, Pedeutour F, Hasselblatt M, Godfraind C (2020) A polyphenotypic malignant paediatric brain tumour presenting a MN1-PATZ1 fusion, no epigenetic similarities with CNS high-grade neuroepithelial tumour with MN1 alteration (CNS HGNET-MN1) and related to PATZ1-fused sarcomas. Neuropathol Appl Neurobiol 46(5):506–509. https://doi.org/10.1111/nan.12626. Epub 2020 Jun 3. PMID: 32397004
Rossi S, Barresi S, Colafati GS, Giovannoni I, Miele E, Alesi V, Cacchione A, Diomedi-Camassei F, Macari G, Antonelli M, Carboni A, Carai A, Mastronuzzi A, Giangaspero F, Gessi M, Alaggio R (2022) Paediatric astroblastoma-like neuroepithelial tumour of the spinal cord with a MAMLD1-BEND2 rearrangement. Neuropathol Appl Neurobiol 48(5):e12814. https://doi.org/10.1111/nan.12814. Epub 2022 Apr 10. PMID: 35301744
Aghabozorgi AS, Bahreyni A, Soleimani A, Bahrami A, Khazaei M, Ferns GA, Avan A, Hassanian SM (2019) Role of adenomatous polyposis coli (APC) gene mutations in the pathogenesis of colorectal cancer; current status and perspectives. Biochimie 157:64–71. https://doi.org/10.1016/j.biochi.2018.11.003. Epub 2018 Nov 8. PMID: 30414835
Hankey W, Frankel WL, Groden J (2018) Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting. Cancer Metastasis Rev 37(1):159–172. https://doi.org/10.1007/s10555-017-9725-6. PMID: 29318445; PMCID: PMC5803335
Rahmani F, Avan A, Hashemy SI, Hassanian SM (2018) Role of Wnt/β-catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer. J Cell Physiol 233(2):811–817. https://doi.org/10.1002/jcp.25897. Epub 2017 May 3. PMID: 28266708
Yuan S, Tao F, Zhang X, Zhang Y, Sun X, Wu D (2020) Role of Wnt/β-catenin signaling in the chemoresistance modulation of colorectal cancer. Biomed Res Int 18(2020):9390878. https://doi.org/10.1155/2020/9390878. PMID: 32258160; PMCID: PMC7109575
Strickland DK, Gonias SL, Argraves WS (2002) Diverse roles for the LDL receptor family. Trends Endocrinol Metab 13(2):66–74. https://doi.org/10.1016/s1043-2760(01)00526-4. PMID: 11854021
Zhen Z, Shen Z, Sun P (2022) Downregulation of low-density lipoprotein receptor-related protein 1B (LRP1B) inhibits the progression of hepatocellular carcinoma cells by activating the endoplasmic reticulum stress signaling pathway. Bioengineered 13(4):9467–9481. https://doi.org/10.1080/21655979.2022.2060778. PMID: 35389768; PMCID: PMC9161869
Lee S (2019) The genetic and epigenetic association of LDL receptor related protein 1B (LRP1B) gene with childhood obesity. Sci Rep 9(1):1815. https://doi.org/10.1038/s41598-019-38538-2. PMID: 30755693; PMCID: PMC6372679
Lu YJ, Wu CS, Li HP, Liu HP, Lu CY, Leu YW, Wang CS, Chen LC, Lin KH, Chang YS (2010) Aberrant methylation impairs low density lipoprotein receptor-related protein 1B tumor suppressor function in gastric cancer. Genes Chromosomes Cancer 49(5):412–424. https://doi.org/10.1002/gcc.20752. PMID: 20095042
Tabouret E, Labussière M, Alentorn A, Schmitt Y, Marie Y, Sanson M (2015) LRP1B deletion is associated with poor outcome for glioblastoma patients. J Neurol Sci 358(1–2):440–443. https://doi.org/10.1016/j.jns.2015.09.345. Epub 2015 Sep 11. PMID: 26428308
Ni S, Hu J, Duan Y, Shi S, Li R, Wu H, Qu Y, Li Y (2013) Down expression of LRP1B promotes cell migration via RhoA/Cdc42 pathway and actin cytoskeleton remodeling in renal cell cancer. Cancer Sci 104(7):817–825. https://doi.org/10.1111/cas.12157. Epub 2013 May 16. PMID: 23521319; PMCID: PMC7657119
Wang Z, Sun P, Gao C, Chen J, Li J, Chen Z, Xu M, Shao J, Zhang Y, Xie J (2017) Down-regulation of LRP1B in colon cancer promoted the growth and migration of cancer cells. Exp Cell Res 357(1):1–8. https://doi.org/10.1016/j.yexcr.2017.04.010. Epub 2017 Apr 11. PMID: 28408316
Heuser M, Beutel G, Krauter J, Döhner K, von Neuhoff N, Schlegelberger B, Ganser A (2006) High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics. Blood 108(12):3898–3905. https://doi.org/10.1182/blood-2006-04-014845. Epub 2006 Aug 15. PMID: 16912223
van Wely KH, Meester-Smoor MA, Janssen MJ, Aarnoudse AJ, Grosveld GC, Zwarthoff EC (2007) The MN1-TEL myeloid leukemia-associated fusion protein has a dominant-negative effect on RAR-RXR-mediated transcription. Oncogene 26(39):5733–5740. https://doi.org/10.1038/sj.onc.1210382. Epub 2007 Mar 19. PMID: 17369854
Mao XM, Li H, Zhang XY, Zhou P, Fu QR, Chen QE, Shen JX, Liu Y, Chen QX, Shen DY (2018) Retinoic acid receptor α knockdown suppresses the tumorigenicity of esophageal carcinoma via Wnt/β-catenin pathway. Dig Dis Sci 63(12):3348–3358. https://doi.org/10.1007/s10620-018-5254-6. Epub 2018 Aug 28. PMID: 30155836
Author information
Authors and Affiliations
Contributions
Luke Mugge – project concept, manuscript preparation, figures preparation. Danielle Dang – background research, manuscript preparation, figures preparation. Kristen Stabingas – manuscript preparation. Gregory Keating – provided clinical care, prepared figures. Christopher Rossi – pathological analysis. Robert Keating – project concept, project supervisor. All authors reviewed the manuscript in its final version.
Corresponding author
Ethics declarations
Ethics approval
The authors affirm the importance of disclosing all financial interests and relationships. No ethical approval was required for this as this involved only one patient, and as such, no consent was needed.
Conflict of interest
All authors above further state that there are no financial relationships or any affiliations which would in any way compromise the integrity of the enclosed manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Mugge, L., Dang, D.D., Stabingas, K. et al. MN1 altered astroblastoma with APC and LRP1B gene mutations: a unique variant in the cervical spine of a pediatric patient. Childs Nerv Syst 39, 1309–1315 (2023). https://doi.org/10.1007/s00381-022-05795-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-022-05795-y